LMR Partners’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-21,449
Closed -$2.04M 1484
2025
Q4
$2.04M Buy
21,449
+2,911
+16% +$293K ﹤0.01% 804
2025
Q3
$1.83M Buy
18,538
+3,038
+20% +$325K 0.01% 762
2025
Q2
$1.65M Buy
15,500
+12,726
+459% +$1.29M 0.01% 685
2025
Q1
$253K Sell
2,774
-2,003
-42% -$224K ﹤0.01% 1024
2024
Q4
$544K Buy
+4,777
New +$545K ﹤0.01% 828
2024
Q3
Sell
-114,846
Closed -$10.6M 1310
2024
Q2
$9.23M Buy
+114,846
New +$10.5M 0.08% 223
2023
Q4
Sell
-31,748
Closed -$3.45M 1005
2023
Q3
$3.45M Sell
31,748
-119,372
-79% -$13.2M 0.04% 315
2023
Q2
$16.3M Buy
151,120
+20,699
+16% +$2.33M 0.18% 127
2023
Q1
$16.2M Buy
130,421
+86,668
+198% +$11.9M 0.25% 101
2022
Q4
$6.57M Sell
43,753
-50,941
-54% -$7.84M 0.11% 219
2022
Q3
$12.8M Sell
94,694
-12,123
-11% -$1.85M 0.23% 90
2022
Q2
$15.9M Buy
106,817
+68,606
+180% +$10.5M 0.27% 79
2022
Q1
$6.52M Sell
38,211
-11,431
-23% -$1.92M 0.08% 270
2021
Q4
$12.8M Buy
+49,642
New +$13.6M 0.13% 135

Other funds holding BNTX

LMR Partners's BNTX Position: Q1 2026 in Review

LMR Partners sold out of BioNTech (BNTX) in Q1 2026, closing a stake of 21,449 shares — an estimated $2.04M sold.

LMR Partners first reported a position in BNTX in Q4 2021 and held it in 14 quarters. The position peaked at $16.3M in Q2 2023. 272 funds tracked by Wall St. Rank hold BNTX as of Q1 2026.

  • LMR Partners reported no remaining BioNTech position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 21,449 BioNTech shares in Q1 2026, an estimated $2.04M.
  • LMR Partners first reported a position in BioNTech in Q4 2021 and held it in 14 quarters.
  • LMR Partners's BioNTech position peaked at $16.3M in Q2 2023.
  • 272 funds tracked by Wall St. Rank held BioNTech as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.